13F-HR filed by Wildcat Capital Management, LLC
Wildcat Capital Management, LLC filed this 13F-HR for the quarter ended 2024-03-31, filed 2024-05-14, with 16 holding rows worth $275,541,458.
- Accession
- 0001999371-24-006054
- Filer
- CIK 1582384
- Filed
- 2024-05-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2024
A holdings report, 16 entries on the cover page, a total value of $275,541,458 stated on the cover page (in dollars after the unit check, H1), rows summing to $275,541,458 with VALUE read as dollars as filed, 13F file number 028-16579. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| GOOSEHEAD INS INC | 38267D109 | COM CL A | 516,008 | $34,376,453 | dollars as filed | |
| FRONTIER COMMUNICATIONS PARE | 35909D109 | COM | 1,412,617 | $34,376,453 | dollars as filed | |
| MOODYS CORP COM | 615369105 | Stock | 82,208 | $32,310,210 | dollars as filed | |
| Microsoft Corp | 594918104 | COM | 75,000 | $31,554,000 | dollars as filed | |
| RLX TECHNOLOGY INC | 74969N103 | SPONSORED ADS | 18,046,195 | $30,710,661 | dollars as filed | |
| GLOBAL-E ONLINE LTD NPV | M5216V106 | SHS | 801,477 | $29,133,689 | dollars as filed | |
| DOORDASH INC CL A | 25809K105 | Stock | 243,683 | $24,097,812 | dollars as filed | |
| META PLATFORMS INC CL A | 30303M102 | COM | 48,814 | $23,703,102 | dollars as filed | |
| ALLOGENE THERAPEUTICS INC | 019770106 | COM | 1,920,787 | $7,877,861 | dollars as filed | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 495,606 | $7,434,090 | dollars as filed | |
| CONSOLIDATED COMMUNICATIONS | 209034107 | COM | 1,494,447 | $6,456,011 | dollars as filed | |
| SKILLZ INC | 83067L109 | COM | 979,848 | $6,359,214 | dollars as filed | |
| COINBASE GLOBAL INC COM CL A | 19260Q107 | Stock | 17,169 | $4,551,845 | dollars as filed | |
| KRONOS BIO INC | 50107A104 | COM | 1,297,959 | $1,687,347 | dollars as filed | |
| NEUMORA THERAPEUTICS INC. | 640979100 | COM | 54,894 | $754,793 | dollars as filed | |
| AKILI INC | 00974B107 | COMMON STOCK | 545,295 | $157,917 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001999371-24-006054 | this filing | 2024-05-14 | acceptance time not in the bulk data set |